Risk factors for gyrA and parC mutations in Pseudomonas aeruginosa

Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America
Valerie C CluzetDarren R Linkin

Abstract

The major mechanism of fluoroquinolone (FQ) resistance in Pseudomonas aeruginosa (PSA) is modification of target proteins in DNA gyrase and topoisomerase IV, most commonly the gyrA and parC subunits. The objective of this study was to determine risk factors for PSA with and without gyrA or parC mutations. Case-case-control study Two adult academic acute-care hospitals Case 1 study participants had a PSA isolate on hospital day 3 or later with any gyrA or parC mutation; case 2 study participants had a PSA isolate on hospital day 3 or later without these mutations. Controls were a random sample of all inpatients with a stay of 3 days or more. Each case group was compared to the control group in separate multivariate models on the basis of demographics and inpatient antibiotic exposure, and risk factors were qualitatively compared. Of 298 PSA isolates, 172 (57.7%) had at least 1 mutation. Exposure to vancomycin and other agents with extended Gram-positive activity was a risk factor for both cases (case 1 odds ratio [OR], 1.09; 95% confidence interval [CI], 1.04-1.13; OR, 1.14; 95% CI, 1.03-1.26; case 2 OR, 1.09; 95% CI, 1.03-1.14; OR, 1.13; 95% CI, 1.01-1.25, respectively). Exposure to agents with extended Gram-positive activity i...Continue Reading

References

Jan 1, 1989·American Journal of Epidemiology·R M Mickey, S Greenland
Oct 1, 1995·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·L M BaddourB G Painter
Feb 7, 1998·Medical Care·A ElixhauserR M Coffey
Feb 13, 1999·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·S Jalal, B Wretlind
May 21, 1999·Archives of Internal Medicine·Y CarmeliM H Samore
Apr 24, 2001·American Journal of Therapeutics·W KhayrA Walters
Jan 5, 2002·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Anthony D HarrisMary-Claire Roghmann
Feb 2, 2002·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·David M Livermore
Feb 19, 2002·Antimicrobial Agents and Chemotherapy·Anthony D HarrisJudith A Johnson
Jul 31, 2003·The Journal of Antimicrobial Chemotherapy·Joseph A PaladinoJerome J Schentag
Feb 25, 2005·The Journal of Antimicrobial Chemotherapy·Donald I HsuAnnie Wong-Beringer
Mar 29, 2005·Antimicrobial Agents and Chemotherapy·Scott T MicekMarin H Kollef
May 4, 2005·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Keith S KayeYehuda Carmeli
Aug 19, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Robert GaynesUNKNOWN National Nosocomial Infections Surveillance System
Dec 27, 2005·Antimicrobial Agents and Chemotherapy·Valerie AloushYehuda Carmeli
Jun 6, 2006·The American Journal of Medicine·Stefan StörkMichiel L Bots
Jun 6, 2006·The American Journal of Medicine·Leanne B GasinkEbbing Lautenbach
Aug 31, 2006·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Ebbing LautenbachNeil O Fishman
Aug 7, 2009·International Journal of Antimicrobial Agents·Neda GorganiNader Pourmand
Mar 29, 2014·TAG. Theoretical and applied genetics. Theoretische und angewandte Genetik·Bilal H AshrafLuc L Janss

❮ Previous
Next ❯

Citations

May 4, 2016·Antimicrobial Agents and Chemotherapy·Yanfang FengBenno H Ter Kuile

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Related Papers

Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America
Larry K KociolekDale N Gerding
Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America
Justine JouCDC Prevention Epicenters Program
© 2021 Meta ULC. All rights reserved